TACR1 and adenomyosis: This would indicate that perioperative intervention to counter either the action of the receptor for substance P, neurokinin receptor 1 (NK1R), or to contain the release of PGE2 by inhibiting COX-2, or the adrenaline receptor would reduce the risk of adenomyosis resulting from EMID [91].